Article Text

Download PDFPDF
Rhomboencephalitis
  1. Jonathan Cleaver1,2,
  2. Richard James3,
  3. Claire M Rice2,4
  1. 1 Department of Neurology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK
  2. 2 Department of Neurology, North Bristol NHS Trust, Bristol, UK
  3. 3 Department of Neuroradiology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK
  4. 4 Clinical Neuroscience, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
  1. Correspondence to Dr Claire M Rice, Clinical Neuroscience, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; C.M.Rice{at}bristol.ac.uk

Abstract

Rhomboencephalitis—inflammation of the brainstem and cerebellum—has myriad clinical presentations including encephalopathy, cranial neuropathies, long tract signs and cerebellar dysfunction and is associated with significant morbidity and mortality. There are a variety of potential underlying causes that respond variably to treatment, including infections, parainfective syndromes, inflammatory disorders including autoimmune encephalitis and paraneoplastic syndromes. Here, we review its clinical presentation and outline a practical approach to its investigation, aiming to facilitate prompt diagnosis and confirmation of the underlying cause, to start appropriate management early and optimise the clinical outcome.

  • infectious diseases
  • immunology
  • neuroimmunology
  • neuropathology
  • virology
  • neurovirology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The manuscript was designed by JC and CMR. All authors contributed to drafting and revision of the manuscript for intellectual content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned. Externally peer reviewed by Emma Tallantyre, Cardiff, UK.

Linked Articles

  • Editors’ commentary
    Phil E M Smith Geraint N Fuller